6th Jan 2011 07:00
06 January 2011 |
Amphion Innovations PLC
Change of Adviser
Amphion Innovations plc (AIM:AMP), the developer of medical and technology businesses, is pleased to announce the appointment of Seymour Pierce Limited as its Nominated Adviser and Broker, with immediate effect.
- Ends -
Enquiries:
Amphion Innovations plc | |
Charlie Morgan | +44 779 953 6043 |
Seymour Pierce Limited (Nominated Adviser) | |
Freddy Crossley | +44 (0) 20 7107 8000 |
Mark Percy | |
Corporate Broking | |
Marianne Woods | |
www.seymourpierce.com |
Cardew Group: | |
Tim Robertson/ Jamie Milton | +44 20 7930 0777 |
About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 8 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number that grows rapidly each year.
On the web: www.amphionplc.com
Related Shares:
AMP.L